BX-517

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBX-517
Drug Alias NameBX-517
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3-phosphoinositide-dependent protein kinase 1 inhibitors
Targets3-phosphoinositide-dependent protein kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBerlex Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBerlex Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A